Advertisement

Marine Biotechnology

, Volume 4, Issue 6, pp 521–525 | Cite as

Sharks: A Potential Source of Antiangiogenic Factors and Tumor Treatments

  • Jung  Cho
  • Young  Kim

Since angiogenesis is a key feature of tumor growth, inhibiting this process is one way to treat cancer. Cartilage is a natural source of material with strong antiangiogenic activity. This report reviews knowledge of the anticancer properties of shark cartilage and clinical information on drugs such as neovastat and squalamine. Because their entire endoskeleton is composed of cartilage, sharks are thought to be an ideal source of angiogenic and tumor growth inhibitors. Shark cartilage extract has shown antiangiogenic and antitumor activities in animals and humans. The oral administration of cartilage extract was efficacious in reducing angiogenesis. Purified antiangiogenic factors from shark cartilage, such as U-995 and neovastat (AE-941), also showed antiangiogenic and antitumor activity. AE-941 is under phase III clinical investigation. Squalamine, a low molecular weight aminosterol, showed strong antitumor activity when combined with chemotherapeutic materials. The angiogenic tissue inhibitor of metalloprotease 3 (TIMP-3) and tumor suppressor protein (snm23) genes from shark cartilage were cloned and characterized.

Keywords

Tumor Growth Tumor Suppressor Oral Administration Antitumor Activity Clinical Information 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag New York Inc. 2002

Authors and Affiliations

  • Jung  Cho
    • 1
  • Young  Kim
    • 1
  1. 1.Department of Microbiology, Pukyong National University, Pusan 608-737, KoreaKR

Personalised recommendations